Thor Medical ASA: Ex. right to participate in subsequent offering today

19 Jun 2025 07:30 CEST

19.6.2025 07:30:01 CEST | Thor Medical ASA | Ex date

Oslo, 19 June 2025: Reference is made to the announcement by Thor Medical ASA
(the "Company") on 18 June 2025 regarding key information on a potential
subsequent offering of shares in the Company. The shares will be traded
exclusive of the right to participate in a potential subsequent offering from
and including today.

Ex. Date: 19 June 2025

This information is published in accordance with the requirements of the
Continuing Obligations for issuers listed on Euronext Oslo Børs.

Contacts

Brede Ellingsæter, CFO & COO Thor Medical, +47 472 38 440,
brede.ellingseter@thormedical.com

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.







ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18570386/6229/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

649561_Download announcement as PDF.pdf